The gay rights movement saw a significant victory at the Supreme Court Wednesday, where the justices struck down part of a law that prohibits federal recognition of same-sex marriages. In a 5-4 ruling, the court struck down Section 3 of the 17-year-old Defense of Marriage Act (DOMA), a provision of the law that denies federal benefits …
I highly encourage everyone to join our important attempt to accelerate the cure of HIV. Research Match also helps connect patients with other diseases with private investigators. Please forward to your friends and families. Anyone can participate. Thank you in advance for supporting this platform! Contact: Kathy Edson (615) 343-2571/ kathleen.edson@vanderbilt.edu ResearchMatch Connects HIV Study Volunteers with Researchers Nashville, TN – June 1, 2013 — ResearchMatch (RM), the country’s first nationwide, non-profit research volunteer recruitment platform for all …
ResearchMatch Connects HIV Study Volunteers with Researchers Read More »
SANGAMO BIOSCIENCES PRESENTS CLINICAL DATA DEMONSTRATING HIV RESERVOIR REDUCTION IN HIV-INFECTED SUBJECTS TREATED WITH ZFP THERAPEUTIC®, SB-728-T Unprecedented Immune Reconstitution Drives HIV Viral Reservoir DepletionEncouraging Preliminary Anti-Viral HIV Data during Treatment Interruption in Ongoing SB-728-T Phase 2 Trials Richmond, California, May 15, 2013 – Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the presentation of new …
CROI 2013 Report Nelson Vergel I was happy to attend CROI-2013 in Atlanta on March 3-6, 2013. These are areas of great interest to me and in no way attempts to summarize the main findings reported at the conference. For abstract information, refer to https://www.retroconference.org/AbstractSearch/default2.aspx?conf=22 A baby girl gets cured The most popular media …
https://www.thebodypro.com/content/71010/timing-and-t-cells-the-evolution-of-when-to-start-.html?ic=700100 Regards, Nelson Sent from my phone so please excuse misspellings and brevity
AIDS: 12 April 2002 – Volume 16 – Issue 6 – pp 934-937 Research Letters Sexual hormones in HIV-infected patients: the influence of antiretroviral therapy Collazos, Julio; Martinez, Eduardo; Mayo, José; Ibarra, Sofia Free Access Article Outline Author Information Section of Infectious Diseases, Hospital de Galdakao, Vizcaya, Spain. Received: 3 August 2001; revised: 16 November …
Sexual hormones in HIV-infected patients: the influence of antiretroviral therapy Read More »
All of the presentations in this section were great. The one on new drugs is contained in the last set of slides (blue slides at 1:22:46) https://webcasts.retroconference.org/console/player/19437?mediaType=podiumVideo For individual reports on each drug (Thanks to Natap.org): NEW HIV DRUGS at CROI Dolutegravir Treatment Response and Safety by Key Subgroups in Treatment Naive HIV Infected Individuals – (03/16/13) Dolutegravir (DTG) …
New HIV Drugs and Formulations in the Near Future (CROI 2013 Presentation) Read More »
NATAP https://natap.org/_______________________________________________ “Functional Cure” of HIV Claimed for Baby Treated 30 Hours After Birth 20th Conference on Retroviruses and Opportunistic Infections, March 3-6, 2013, Atlanta Mark Mascolini An HIV-infected US infant treated from 30 hour after birth had no detectable viral load, no detectable HIV DNA in blood cells, and no HIV-specific antibodies at 26 months …
“Functional Cure” of HIV Claimed for Baby Treated 30 Hours After Birth Read More »
Reality Check: Is the End of AIDS in Sight? Dr Francois Dabis from the Bordeaux School of Public Health at the University of Bordeaux (Segalen, France) gave an excellent talk today at CROI-2013 that is easily understood by any lay person who wants to know how far we have come in HIV and the challenges ahead …
Dear HIV Community Writer, ViiV Healthcare has taken the decision to stop the development program investigating the non-nucleoside reverse transcriptase inhibitor (NNRTI), lersivirine. This is not due to any safety concerns regarding the compound. ViiV Healthcare’s goal is to support the best possible outcomes for people living with HIV, and to deliver new therapies that …
GSK – ViiV Abandons Lersivirine – An Investigational NNRTI HIV Medication Read More »
At least, for vaginal sex…(no data on anal sex!) The statement notes that there is now conclusive randomised clinical trial evidence, from the HPTN 052 trial, to show that transmission of HIV through vaginal sex is significantly reduced when an HIV-positive person is taking effective antiretroviral therapy (ART). In this trial, early treatment reduced HIV transmission …
